Clinical Trials

Clinical trials should be every patient's starting point when it comes to pancreatic cancer. Find out about trials that are available today, and the cutting-edge research available to patients.

151 Articles

against a dark blue background, transparent tubes in orange, lighter blue, red, and clear, indicate different aspects of cell transport. The image was created through an electron microscope.
Research
December 22, 2016 • 2 Min

A New Approach to Treating Some Advanced Pancreatic Cancer Patients

A clinical trial uses PEGPH20, a synthetic form of a human enzyme, to make treatment more effective in pancreatic cancer patients with high tumor pressure.

Abstract black and white image of laboratory equipment and tubes
Research
December 9, 2016 • 2 Min

Muting Chemical Signals to Slow or Stop the Spread of Pancreatic Cancer

A clinical trial tests a drug that turns off chemical signals in the body that promote the growth of tumors and the spread of pancreatic cancer.

glass laboratory pipettes
Research
December 6, 2016 • 4 Min

The First Line of Defense against Pancreatic Cancer

Drs. Allyson Ocean and David Tuveson explain why pancreatic cancer patients should participate in clinical trials at the time of diagnosis.

Illustration of the twisting spirals of two DNA double helices in royal blue and purple on a turquoise colored background
Research
October 18, 2016 • 2 Min

A New Drug Combination to Control Advanced Pancreatic Cancer

A clinical trial for pancreatic cancer patients with the BRCA mutation tests the effectiveness of standard treatment plus a PARP inhibitor.

Microscope image of four pancreatic cells with pinkish edges and green centers, against a dark background
Research
October 10, 2016 • 2 Min

A Novel Combination to Slow Pancreas Tumors that Cannot Be Surgically Removed

Can a combination of standard drugs, a PARP inhibitor, and intensity modulated radiation therapy to slow pancreatic tumor growth?

Cancer researcher Sunil Hingorani
Research
September 19, 2016 • 4 Min

New Drug Shows Positive Results in Early Trials

A new drug called PEGPH20, which helps chemotherapy drugs reach their target, is showing positive results in an ongoing pancreatic cancer trial.

Close up of a microscope in lighting with blues, purples and greens
Research
September 14, 2016 • 2 Min

Slowing the Growth of Pancreatic Tumors Before Surgery

A chemoradiation clinical trial tests standard chemotherapy plus an anti-malaria drug and compares two types of radiation treatments, to slow tumor growth.

Micrograph of pancreatic ductal adenocarcinoma showing cells in pink and dark purple with white spaces between.
Research
August 31, 2016 • 2 Min

A New Chemotherapy and Radiation Regimen to Shrink Tumors Before Surgery

Researchers are testing a new combination of chemotherapies and radiation to shrink pancreatic cancer tumors and make surgical removal possible.

Microscopy image of a tumor section (obtained from a mouse tumor model) shows the blue-stained nanoparticles selectively accumulating in the peripheral tumor area and then penetrating into tumor cells
Research
August 18, 2016 • 2 Min

Exploring the Effectiveness of an Experimental Class of Drug

Does adding a PARP inhibitor drug to standard treatment help control the spread of advanced pancreatic cancer in patients with the BRCA mutation?

Illustration of the DNA double helix in red, blue, purple, yellow, orange, and green. There is a main spiral in the center and two faded spirals on the left and right.
Research
August 10, 2016 • 2 Min

Using a Colon Cancer Drug to Treat Advanced Pancreatic Cancer

A clinical trial tests the effectiveness of an approved colon cancer drug against advanced pancreatic neuroendocrine cancer.

Microscope image of a yellow cell with white cells around it and partly reaching on it, on a teal background
Research
July 13, 2016 • 2 Min

Testing the Effect of a Malaria Drug on Standard Treatment

A clinical trial tests whether a malaria drug can make standard chemotherapy for advanced pancreatic cancer more effective.

illustration of the DNA double helix in purple and dark gray on a turquoise background
Research
June 30, 2016 • 2 Min

Discovering the Better Drug Treatment After Surgery for Pancreatic Cancer

A clinical trial compares two chemotherapy regimens to see which one is more effective at knocking out remaining cancer cells.

silver microscope
Research
June 17, 2016 • 2 Min

Exploring the Better Treatment for Stable Metastatic Pancreatic Cancer

For patients with stable metastatic pancreatic cancer, a clinical trial compares standard chemotherapy with immunotherapy.

Big blue gloves handling lab samples
Research
June 6, 2016 • 2 Min

Patients Needed for Clinical Trial/Research Study of Treatment Targeting Immune System

A clinical trial seeks pancreatic cancer patients with the MSI (microsatellite instability) genetic signature, to test an immunotherapy drug.

microscope image of pancreatic cancer--the blue irregular circles on the left--and normal pancreas cells--the smaller circles on the right
Research
June 3, 2016 • 2 Min

Low-Dose Continuous Chemotherapy as Part of a New Combination of Drugs

A clinical trial uses a new immunotherapy drug in combination with standard chemotherapy drugs in metronomic therapy to treat metastatic pancreatic cancer.